Protocol GLI.04.US.SL.020 CONFIDENTIALInvestigator Agreement • November 1st, 2023
Contract Type FiledNovember 1st, 2023Title A randomized, single-center, prospective biopsy study comparing a poly L-lactic acid biostimulator and a calcium hydroxylapatite semi-permanent filler Protocol number: GLI.04.US.SL.020 Sponsor name and address: Galderma Laboratories, L.P. 14501 North FreewayFort Worth, TX 76177 USA Study treatment products: Sculptra® Radiesse® (+) Investigator agreement: I have read the clinical study described herein, recognize its confidentiality, and agree to conduct the described study in compliance with Good Clinical Practices (GCP), the ethical principles contained within the Declaration of Helsinki, this protocol, and all applicable regulatory requirements. Principle Investigator: Signature Date Investigator name: Jill S. Waibel, MD Address: Miami Dermatology & Laser Institute 7800 SW 87th Avenue, Suite B200 Miami, FL 33173USATelephone: (305) 279-6060